KWAK; Larry W.
Patent Applications and Registrations
Patent applications and USPTO patent grants for KWAK; Larry W..The latest application filed is for "baff-r bispecific t-cell engager antibody".
- KWAK; Larry W. - Pasadena CA
- KWAK; Larry W. - Duarte CA
- Kwak; Larry W. - Bellaire TX
- Kwak; Larry W. - Houston TX US
- Kwak; Larry W. - Frederick MD
| Patent | Date |
|---|---|
| Baff-r Bispecific T-cell Engager Antibody App 20220056132 - QIN; Hong ; et al. | 2022-02-24 |
| Baff-r Antibodies And Uses Thereof App 20220041743 - QIN; Hong ; et al. | 2022-02-10 |
| Baff-r Targeted Chimeric Antigen Receptor-modified T-cells And Uses Thereof App 20220010023 - QIN; Hong ; et al. | 2022-01-13 |
| BAFF-R targeted chimeric antigen receptor-modified t-cells and uses thereof Grant 11,161,908 - Qin , et al. November 2, 2 | 2021-11-02 |
| BAFF-R antibodies and uses thereof Grant 11,136,405 - Qin , et al. October 5, 2 | 2021-10-05 |
| Anti-Baff Receptor Antibodies and Uses Thereof App 20210261676 - Zhang; Jianbing ; et al. | 2021-08-26 |
| Baff-r Bispecific T-cell Engager Antibody App 20200199232 - Qin; Hong ; et al. | 2020-06-25 |
| Baff-r Antibodies And Uses Thereof App 20200190204 - QIN; Hong ; et al. | 2020-06-18 |
| Antibody Variable Domains And Antibody Constructs App 20200071418 - QIN; Hong ; et al. | 2020-03-05 |
| Baff-r Targeted Chimeric Antigen Receptor-modified T-cells And Uses Thereof App 20190263917 - QIN; Hong ; et al. | 2019-08-29 |
| Tumor-specific Gm-csf Cytokine Response As Predictor Of Cancer Vaccine Effectiveness App 20140363456 - Wilson; Wyndham H. ; et al. | 2014-12-11 |
| Defensin-antigen Fusion Proteins App 20140234362 - Kwak; Larry W. ; et al. | 2014-08-21 |
| Defensin-antigen fusion proteins Grant 8,754,030 - Kwak , et al. June 17, 2 | 2014-06-17 |
| Defensin-antigen Fusion Proteins App 20140004113 - Kwak; Larry W. ; et al. | 2014-01-02 |
| Defensin-antigen fusion proteins Grant 8,551,936 - Kwak , et al. October 8, 2 | 2013-10-08 |
| Viral Chemokine-antigen Fusion Proteins App 20130224199 - Kwak; Larry W. ; et al. | 2013-08-29 |
| Viral chemokine-antigen fusion proteins Grant 8,460,675 - Kwak , et al. June 11, 2 | 2013-06-11 |
| Viral chemokine-antigen fusion proteins Grant 8,318,177 - Kwak , et al. November 27, 2 | 2012-11-27 |
| Viral Chemokine-antigen Fusion Proteins App 20120276101 - Kwak; Larry W. ; et al. | 2012-11-01 |
| Defensin-antigen Fusion Proteins App 20120134954 - Kwak; Larry W. ; et al. | 2012-05-31 |
| Defensin-antigen fusion proteins Grant 8,084,250 - Kwak , et al. December 27, 2 | 2011-12-27 |
| Defensin-antigen Fusion Proteins App 20110135715 - Kwak; Larry W. ; et al. | 2011-06-09 |
| Viral Chemokine-antigen Fusion Proteins App 20110110947 - Kwak; Larry W. ; et al. | 2011-05-12 |
| Defensin-antigen fusion proteins Grant 7,915,040 - Kwak , et al. March 29, 2 | 2011-03-29 |
| Viral chemokine-antigen fusion proteins Grant 7,897,152 - Kwak , et al. March 1, 2 | 2011-03-01 |
| Defensin-antigen Fusion Proteins App 20100260793 - Kwak; Larry W. ; et al. | 2010-10-14 |
| Defensin-antigen fusion proteins Grant 7,754,676 - Kwak , et al. July 13, 2 | 2010-07-13 |
| Defensin-antigen fusion proteins App 20050095257 - Kwak, Larry W. ; et al. | 2005-05-05 |
| Viral chemokine-antigen fusion proteins App 20040110165 - Kwak, Larry W. ; et al. | 2004-06-10 |
| Chemokine-tumor antigen fusion proteins as cancer vaccines App 20030138452 - Kwak, Larry W. ; et al. | 2003-07-24 |
| Chemokine-tumor antigen fusion proteins as cancer vaccines Grant 6,562,347 - Kwak , et al. May 13, 2 | 2003-05-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 